Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 32
	QLoRA Alpha: 48.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is associated with an increased risk of morbidity in neonates. This association is independent of birth weight percentile. In addition, BF% may be a more useful marker for undernutrition in neonates than birth weight percentile. Further studies are needed to validate these findings. It is suggested that clinicians should consider BF% when assessing nutritional status in preterm infants. These results have important implications for policy makers, health care providers, and researchers working to improve infant health. Further work is required to determine the impact of this finding on infant mortality rates. A larger sample size would facilitate further investigation into whether BF% can be used as a predictor of morbidity in neonates. Further studies are also needed to investigate the relationship between BF% and morbidity in other populations.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.5
Reasoning:
The assistant’s reply correctly conveys the key finding that low BF% is associated with higher neonatal morbidity and that BF% may better identify undernourished neonates than birth weight percentiles. However, it makes two problematic claims: (1) it states the association is “independent of birth weight percentile” without clear support from the presented results, and (2) it inappropriately generalizes a recommendation to “preterm infants” even though the study sampled term neonates (≥37 wk). The suggestions for further study are reasonable but the clinical/policy recommendations are stronger than the evidence warrants.

conciseness: 0.4
Reasoning:
The response states the key conclusion (low BF% is linked to higher neonatal morbidity and may be a better marker than birth weight percentile) but is not very concise: it repeats the need for further studies multiple times, adds extraneous recommendations (mentions preterm infants though the study involved term neonates), and includes broad policy implications that go beyond the direct answer. Overall it answers the question but with unnecessary verbosity and minor inaccuracy.

relevance: 0.3
Reasoning:
The assistant's reply addresses the question (it states BF% may be more useful than birth weight percentiles) but it fails to refer to or quote the actual findings from the context (no ORs, rates, or the ground-truth sentence are cited). It also includes at least two inaccuracies relative to the provided context: it asserts the association is "independent of birth weight percentile" (the context reports both associations but does not state independence) and it recommends considering BF% in "preterm infants" despite the study enrolling term (≥37 wk) neonates. Overall, relevant to the question but not grounded in the specific quoted context and contains incorrect/unsupported claims.

coherence: 0.5
Reasoning:
The response is generally coherent and addresses the question directly (it states that low BF% is associated with higher neonatal morbidity and suggests BF% may be a better marker than birth weight percentiles). However it has problems: it makes an unsupported claim that the association is “independent” of birth weight percentiles (the provided summary does not state independence), it incorrectly advises clinicians about preterm infants though the study included term neonates, and it includes several repetitive and extraneous recommendations (policy implications, mortality) not grounded in the presented data. Overall the answer is organized but contains factual inaccuracies and unnecessary content.

helpfulness: 0.4
Reasoning:
The response captures the main takeaway — that low BF% is associated with higher neonatal morbidity and may be a better marker than birth weight percentiles — and appropriately hedges that further study is needed. However, it has important problems: it incorrectly recommends clinicians consider BF% in preterm infants when the study enrolled term neonates; it asserts the association is "independent" of birth weight percentiles without showing evidence of adjustment or presenting the comparative statistics (the study actually reports a stronger OR for BF% than for birth weight percentiles); it omits the specific finding that BF% can identify undernourished infants who are appropriately grown and exclude small infants not at risk; and it repeats generic calls for more research rather than summarizing quantitative results that support the conclusion. Because of these inaccuracies and omissions the answer is only partially helpful.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: Our experience suggests that ischemic Charcot neuroarthropathy can be successfully treated with combined endovascular and surgical methods. However, it seems that the treatment of this pathology differs from that of other forms of Charcot foot. Further studies are needed to confirm these results. Nevertheless, we recommend the use of combined treatments in the management of this disease.
Therefore, we suggest that further investigations should focus on defining the characteristics of ischemic Charcot neuroarthropathy and its potential outcome. We propose a prospective study to define the best approach to manage this condition. This would help us to better understand the clinical features, prognosis and treatment options for patients affected by ischemic Charcot neuroarthropathy. Future studies will allow us to establish an evidence-based approach to this disease.
In conclusion, the treatment of ischemic Charcot neuroarthropathy should be considered as a separate entity and should not be compared with non-ischemic forms of the disease. Our findings suggest that the combination of endovascular and surgical techniques can be effective in achieving a good outcome for patients affected by ischemic Charcot neuroarthropathy. Further studies are needed to validate these results and to determine whether there are any specific factors associated with a better outcome in ischemic Charcot neuroarthropathy.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.7
Reasoning:
The assistant's reply is generally consistent with the study's implication that ischemic Charcot neuroarthropathy is managed differently from non‑ischemic Charcot and that combined endovascular (revascularization) plus surgical/orthopedic treatment can support limb salvage. However, the response overstates certainty by calling it a separate entity "and should not be compared" with non‑ischemic forms, does not explicitly state that revascularization is necessary to enable the surgical/orthopedic management, and omits reporting the study's key outcome measures (90% limb salvage, mean healing time ≈197 days) and the small retrospective sample size—important limitations that temper conclusions. The suggestion for further prospective study is appropriate.

conciseness: 0.4
Reasoning:
The response reaches the correct conclusion (that ischemic Charcot neuroarthropathy likely requires a different, combined treatment approach) but is wordy and repetitive, repeatedly calling for further studies and restating the same points. It also misses an opportunity to concisely cite the study's key outcomes (90% limb salvage, mean healing time ~197 days). Overall it is not concise or tightly focused on the question.

relevance: 0.6
Reasoning:
The response is generally relevant: it answers the question by stating that ischemic Charcot neuroarthropathy appears to require a different (combined endovascular plus surgical) approach than non‑ischemic Charcot foot, which aligns with the study context. However, it misses key concrete findings from the provided data (for example, the 90% limb‑salvage rate, the need for revascularization to support surgical/orthopedic treatment, and the mean healing time ~197 days) and makes a strong conclusion about treating the condition as a separate entity without citing those study results. The reply is also repetitive and emphasizes further studies more than summarizing the actual evidence.

coherence: 0.7
Reasoning:
The response is generally coherent and organized: it states a clear conclusion (combined endovascular and surgical treatment is effective), recommends further research, and calls for treating ischemic Charcot neuroarthropathy as a distinct entity. However, it is repetitive, lacks specific data from the presented study (e.g., 90% limb salvage, mean healing time ~197 days), and makes somewhat strong definitive statements without tying them to the reported results. Overall the answer is readable and logically structured but could be more concise and evidence-linked.

helpfulness: 0.6
Reasoning:
The assistant's reply is broadly aligned with the study's implication that ischemic Charcot neuroarthropathy is best managed with combined revascularization plus surgical/orthopedic care and that its management may differ from non‑ischemic Charcot foot. However, the response is vague and repetitive, omits key study details (for example the reported 90% limb‑salvage rate and the mean healing time ~197 days), and stops short of explicitly stating that revascularization is necessary to support surgery and avoid amputation. It also asserts that ischemic Charcot should be treated as a separate entity without providing sufficient evidence or nuance. Overall it is moderately helpful but could be more specific and evidence‑based.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: The present results suggest that surgical treatment of endometrial cancer with suspected cervical involvement may not be justified in all cases. In addition to conservative management, it is necessary to perform radical hysterectomy to improve patient outcome. The use of adjuvant chemotherapy should also be considered according to the clinical stage. This study has shown that surgical approach does not affect patient outcomes. Therefore, radical hysterectomy may not be necessary when cervical involvement is suspected. Patients with endometrial cancer with suspected cervical involvement should be managed using a multidisciplinary approach that includes a gynecologist, medical oncologist, radiologist, and pathologist. Further studies are required to determine whether RH is necessary in these cases. This study will help us understand whether RH is necessary in these cases. The authors recommend further studies to clarify this issue. They believe that patients with endometrial cancer who have suspected cervical involvement should be managed according to the clinical stage. We conclude that the current evidence does not support the use of radical hysterectomy for endometrial cancer with suspected cervical involvement. The current study did not demonstrate any difference in the overall survival between patients who underwent radical hysterectomy and those who underwent other types of hysterectomy. Radical hysterectomy is still performed for endometrial cancer with suspected cervical involvement. However, the current evidence suggests that there may be no need for radical hysterectomy if the patient's disease is limited to the cervix. A randomized trial would be useful to address this question. It is important to note that the current data do not support the use of radical hysterectomy for endometrial cancer with suspected cervical involvement. The authors suggest that surgical treatment should be based on the clinical stage rather than the presence or absence of cervical involvement. We propose that patients with endometrial cancer with suspected cervical involvement should be managed by a multidisciplinary team of physicians and that the decision regarding surgical treatment should be made after a thorough discussion of the risks and benefits. Further studies are needed to confirm these findings and to develop guidelines for the management of endometrial cancer with suspected cervical involvement. We conclude that the current data do not support the use of radical hysterectomy for endometrial cancer with suspected cervical involvement. The current study did not show any difference in overall survival between patients who underwent radical hysterectomy and those who underwent other types of hysterectomy. Radical hysterectomy is still performed for endometrial cancer with suspected cervical involvement. However, the current evidence suggests that there may be no need for radical hysterectomy if the patient's disease is limited to the cervix. The authors suggest that surgical treatment should be based on the clinical stage rather than the presence or absence of cervical involvement. Patients with endometrial cancer with suspected cervical involvement should be managed by a multidisciplinary team of physicians. The decision regarding surgical treatment should be made after a thorough discussion of the risks and benefits.
Question:
Does radical hysterectomy improve survival in patients with endometrial cancer with suspected cervical involvement?


Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.2
Reasoning:
The assistant's reply is muddled and internally contradictory, contains repeated text, and omits or misstates key trial findings. The GOTIC-005 data show no survival benefit from radical hysterectomy (RH) and identify age, grade, peritoneal cytology, and lymph node status — not hysterectomy type — as prognostic factors; RH was associated with longer operative time, more transfusions, and greater urinary morbidity. The assistant both correctly states that RH may not be necessary and incorrectly claims RH is "necessary to perform" in the same answer, and it fails to clearly report the increased perioperative/late adverse events. For these reasons the response is inaccurate and unclear.

conciseness: 0.2
Reasoning:
Short explanation: The assistant's reply is verbose, repetitive, and internally contradictory (it at one point states RH is necessary, then repeatedly concludes it is not). It fails to give a single concise, clear answer to the question. Although the correct conclusion (no survival benefit from radical hysterectomy and higher morbidity) appears implicitly, it is buried in redundancy and mixed statements, making the response unclear and not concise.

relevance: 0.3
Reasoning:
The assistant's reply does attempt to answer the question and repeatedly states the study's main conclusion (that radical hysterectomy did not improve overall survival), and it alludes to multidisciplinary management and need for further study. However the response is poorly written: it is repetitive, contains a direct contradiction ("it is necessary to perform radical hysterectomy" vs. multiple statements that RH may not be necessary), and does not cite or accurately paraphrase specific outcomes from the context (e.g., higher perioperative/late adverse events with RH are not clearly described). Because of the contradiction and lack of concise, accurate reference to the study findings, the answer's relevance and clarity are low.

coherence: 0.2
Reasoning:
The assistant's reply is poorly coherent. It contains direct contradictions (saying RH "may not be justified" and immediately that it is "necessary"), is highly repetitive, and lacks clear structure. It repeats the same conclusions multiple times instead of summarizing the study findings concisely, and it omits important study details (e.g., RH was associated with longer operative time, higher transfusion rates and more urinary dysfunction) that are relevant to judging whether RH is needed. Overall the answer fails to present a clear, concise conclusion supported by the study text.

helpfulness: 0.3
Reasoning:
The assistant's reply reaches the correct general conclusion (no survival benefit of radical hysterectomy for suspected cervical involvement) and appropriately calls for multidisciplinary decision-making and further studies. However, the answer is poorly written: it is repetitive, contains direct contradictions (saying RH is both “necessary” and “may not be necessary”), adds unsupported statements (e.g., recommending adjuvant chemotherapy without study-specific evidence), and fails to clearly report an important finding from the study that RH had higher perioperative and late adverse events. Overall the response is confusing and not reliably helpful despite touching the right conclusion.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Hospital readmissions after PD may be associated with increased cost, morbidity, and mortality. Prevention of readmissions should focus on identifying high-risk patients and optimizing their care through improved communication, patient education, and surveillance. Optimal management of risk factors such as pancreatic fistula, prolonged initial hospitalization, and ICU admission could reduce the likelihood of readmission. Improved perioperative care, including earlier recognition of complications, prompt treatment, and close monitoring, may also help to reduce readmissions. Furthermore, regular assessment of the patients' nutritional status, pain control, and wound healing may decrease the likelihood of readmission due to delayed gastric emptying or wound infection. Finally, improving patient satisfaction, reducing anxiety, and promoting good self-care practices would help to avoid readmissions due to poor coping mechanisms. Further studies should focus on developing standardized protocols for prehospitalization counseling and postoperative surveillance to improve outcomes and reduce readmissions. However, it is important to note that readmission rates remain high, and there is an urgent need to develop strategies for further reduction.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.6
Reasoning:
The assistant's reply is generally reasonable and mentions several relevant risk factors (pancreatic fistula, prolonged initial hospitalization, ICU admission) and sensible prevention strategies (identifying high‑risk patients, enhanced monitoring, patient education, early recognition/treatment). However it misses two key, study‑specific conclusions: it does not explicitly identify the complexity of the initial resection (multivisceral/complex resection) as an independent predictor of readmission, and it fails to emphasize that about half of readmissions occur within 7 days and that efforts should particularly target preventing these early readmissions. The recommendations are also fairly generic and not tied to the study's specific timing- and cause-related differences for early versus late readmissions.

conciseness: 0.6
Reasoning:
The response covers relevant preventive strategies and correctly mentions pancreatic fistula, prolonged initial hospitalization, and ICU admission as targets — but it omits explicit mention of resection complexity (multivisceral resection) as an independent risk factor and fails to highlight that about half of readmissions are early and should be a primary focus. The answer is somewhat wordy and offers general recommendations rather than a concise, targeted summary tied to the key study findings.

relevance: 0.6
Reasoning:
The assistant's reply is generally relevant and addresses prevention of readmissions after PD, and it correctly cites risk factors that appear in the context (pancreatic fistula, prolonged initial hospitalization, ICU admission). However it omits another key context finding — the association with complex/multivisceral resection — and fails to note the important temporal point from the text that half of readmissions occur within 7 days and that efforts should particularly target early readmissions. The recommendations given are mostly generic (education, surveillance, nutrition, wound care) rather than being specifically tied to the study's distinct findings about early versus late readmissions.

coherence: 0.6
Reasoning:
The response is coherent, well organized, and gives sensible, general strategies to reduce readmissions after PD (risk stratification, patient education, surveillance, early complication recognition, nutrition and wound care). However it omits or underemphasizes two key, study-specific findings: (1) that complexity of the initial resection (multivisceral resection) was an independent predictor of readmission, and (2) that half of readmissions occur early (≤7 days) so efforts should particularly target preventing early readmissions. Because the answer is clear and relevant but incomplete with respect to the study's principal conclusions, I rate it as follows.


helpfulness: 0.6
Reasoning:
The response is generally helpful and relevant: it correctly highlights known risk factors (pancreatic fistula, prolonged initial stay, ICU admission) and gives reasonable prevention strategies (risk stratification, better communication/education, closer postoperative surveillance, attention to nutrition/wound care). However it misses two important, study-specific points: (1) it does not mention the complexity of the initial resection (multivisceral/complex resections) as an independent predictor, and (2) it fails to emphasize that about half of readmissions occur very early (≤7 days) and therefore prevention efforts should particularly target early postdischarge surveillance and interventions. The recommendations are also somewhat high-level and lack specific, actionable measures tied to the study findings (e.g., targeted drain management or early outpatient follow-up protocols). Overall a moderately useful answer but incomplete relative to the ground truth.

================================================================================
Average correctness Score: 0.45
Average conciseness Score: 0.49
Average relevance Score: 0.5
Average coherence Score: 0.54
Average helpfulness Score: 0.47
